Analysis of Potential Risk Factors for Multidrug-Resistance at a Burn Unit

IF 1 Q4 CRITICAL CARE MEDICINE European burn journal Pub Date : 2023-01-11 DOI:10.3390/ebj4010002
L. Cabral, Leonor Rodrigues, A. Tavares, Gonçalo Tomé, Marisa Caetano, C. Chaves, V. Afreixo
{"title":"Analysis of Potential Risk Factors for Multidrug-Resistance at a Burn Unit","authors":"L. Cabral, Leonor Rodrigues, A. Tavares, Gonçalo Tomé, Marisa Caetano, C. Chaves, V. Afreixo","doi":"10.3390/ebj4010002","DOIUrl":null,"url":null,"abstract":"Background: Infections by multidrug-resistant (MDR) microorganisms are associated with increased morbidity and mortality in burn patients. This study aimed to analyze the evolution of MDR bacteria over a five-year period at Coimbra Burns Unit (CBU) in Portugal, seeking to assess the possible associations of specific bacteria with presumed risk factors. Methods: The data obtained consisted of identified bacteria present in any microbiological sample from each patient (including blood, central venous catheter, urine, tracheal aspirate and/or wound exudate). Univariate models and a multivariate model were constructed for each of the MDR bacteria species that infected at least 50 patients or that had five or more MDR strains. Statistical hypothesis tests with a p-value less than 0.05 were considered significant. Results: Of a total of 341 samples obtained, 107 were MDR, corresponding to 10 species. Globally, there was no significant variation in MDR bacteria frequency over the period under analysis. Some risk factors and/or trends were identified for some species, but none was linked to all of them. Conclusions: The risks for the development of MDR in bacteria in burn patients are multifactorial, mainly linked to longer hospital stays, the use of invasive devices and inadequate antimicrobial treatment. However, the influence of these risks regarding specific bacterial species is not straightforward and may rely on individual characteristics, type of treatment and/or local prevalent flora. Due to the severity of multidrug-resistant infections, continued microbiological surveillance with the aid of rapid diagnostic tests and prompt institution of appropriate antimicrobial therapy are crucial to improving outcomes for burn patients.","PeriodicalId":72961,"journal":{"name":"European burn journal","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2023-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European burn journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/ebj4010002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Infections by multidrug-resistant (MDR) microorganisms are associated with increased morbidity and mortality in burn patients. This study aimed to analyze the evolution of MDR bacteria over a five-year period at Coimbra Burns Unit (CBU) in Portugal, seeking to assess the possible associations of specific bacteria with presumed risk factors. Methods: The data obtained consisted of identified bacteria present in any microbiological sample from each patient (including blood, central venous catheter, urine, tracheal aspirate and/or wound exudate). Univariate models and a multivariate model were constructed for each of the MDR bacteria species that infected at least 50 patients or that had five or more MDR strains. Statistical hypothesis tests with a p-value less than 0.05 were considered significant. Results: Of a total of 341 samples obtained, 107 were MDR, corresponding to 10 species. Globally, there was no significant variation in MDR bacteria frequency over the period under analysis. Some risk factors and/or trends were identified for some species, but none was linked to all of them. Conclusions: The risks for the development of MDR in bacteria in burn patients are multifactorial, mainly linked to longer hospital stays, the use of invasive devices and inadequate antimicrobial treatment. However, the influence of these risks regarding specific bacterial species is not straightforward and may rely on individual characteristics, type of treatment and/or local prevalent flora. Due to the severity of multidrug-resistant infections, continued microbiological surveillance with the aid of rapid diagnostic tests and prompt institution of appropriate antimicrobial therapy are crucial to improving outcomes for burn patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
某烧伤科多药耐药潜在危险因素分析
背景:耐多药(MDR)微生物感染与烧伤患者发病率和死亡率增加有关。本研究旨在分析葡萄牙科英布拉烧伤科(CBU) 5年期间耐多药细菌的演变,试图评估特定细菌与假定危险因素的可能关联。方法:获得的数据包括来自每位患者的任何微生物样本(包括血液、中心静脉导管、尿液、气管吸入物和/或伤口渗出物)中存在的已鉴定细菌。对感染至少50例患者或有5种或更多耐多药菌株的每一种耐多药细菌构建单因素模型和多因素模型。p值小于0.05的统计假设检验被认为是显著的。结果:341份标本中,耐多药107份,对应10种;在全球范围内,耐多药细菌的频率在分析期间没有显著变化。一些风险因素和/或趋势被确定为某些物种,但没有一个与所有物种相关。结论:烧伤患者细菌发生耐多药耐药的风险是多因素的,主要与住院时间较长、使用侵入性器械和抗菌药物治疗不充分有关。然而,这些风险对特定细菌种类的影响并不直接,可能取决于个体特征、治疗类型和/或当地流行菌群。由于耐多药感染的严重程度,在快速诊断测试的帮助下持续进行微生物监测,并及时实施适当的抗菌药物治疗,对于改善烧伤患者的预后至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Balance Impairment in the Burn Population: A Burn Model System National Database Study Resource Requirements in a Burn Mass Casualty Event Hypnosis in Burn Care: Efficacy, Applications, and Implications for Austere Settings Qualitative Descriptive Research Investigating Burn Survivors’ Perspectives on Quality of Care Aspects European Burns Association (EBA)—Summer 2024 News
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1